Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for adults with obesity, or overweight with weight-related medical problems. When used alongside a reduced- calorie diet and increased physical activity, Foundayo helps individuals lose excess body weight and keep the weight off. Foundayo will be available […] The post FDA approves Lilly’s Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions appeared first on Web-Release.
Breaking News:
- Drugstore Baabda Celebrates 10 Years of Trust, Care and Commitment to the Community
- Moscow International Game Week to Strengthen Gaming Ties with MENA and Türkiye
- OPPO Find X10 Series Launches in the GCC with True-to-Life Imaging and All-Round Flagship Upgrades
- LG ELECTRONICS BRINGS ITS HERITAGE OF CUSTOMER-CENTRIC INNOVATION TO TIMES SQUARE
- CMA CGM Boosts Lebanese Apple Exports to Egypt, Libya, and KSA with Special Shipping Rates
- Aster Hospital Al Qusais Launches Dedicated Breast Clinic to Provide Comprehensive, Coordinated Breast Care
- Make your special day more magical and create your dream wedding at the Radisson Resort Ras Al Khaimah Marjan Island
- Twice the Taste, One Sweet Deal: Brunch for Two at Prego’s for AED 295
Saturday, October 24